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Advanced glaucoma at presentation is associated with poor follow up amongst glaucoma patients 
attending a tertiary eye facility in Southern Nigeria. 
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ABSTRACT  
Purpose:  Globally, particularly in Africa, poor compliance with medication is a major problem in 
glaucoma management but little is known about follow-up rates among African glaucoma patients. 
The aim of this study was to determine rates of follow-up among glaucoma patients attending a 
tertiary hospital in southern Nigeria and investigate predictors of poor follow-up. 
Methods: Data were extracted from medical records of new glaucoma patients who attended the 
hospital between June 2011 and May 2013. Socio-demographic and clinical parameters (visual 
acuity; stage of glaucoma) recorded at diagnosis were extracted using a pre-tested form. Follow-up 
was defined as good if they had attended within 9 months of the study date, inadequate when the 
last follow-up was more than 9 months and failed if they did not attend any follow-up or the most 
recent visit was more than 14 months from the study date. Univariate and multivariable analyses 
were undertaken to explore predictors of poor follow-up (inadequate plus failed).  
Results: 348 patients were recruited, 54% were male and the mean age was 52.7 (range 16-88) 
years.  Follow-up was as follows:  good 28.4%, inadequate 46.6%, failed 25%. Overall 71.6% had poor 
follow-up. Independent predictors of poor follow-up were poorer visual acuity (OR 3.85, 95% 
confidence interval (CI) 1.25-11.80 for visual impairment; OR 4.11, 95% CI 1.32-12.81 for blind) and 
end-stage glaucoma (OR 3.55 (1.31-9.62), p=0.01). 
Conclusion: Enhanced counselling of patients with moderate to advanced glaucoma and visual 
impairment is required to improve follow-up and hence glaucoma management. 
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INTRODUCTION 
At the first African Glaucoma Summit in Accra, Ghana in 2010, the World Glaucoma Association 
stated that blindness from glaucoma is an important cause of blindness globally, and in Sub Saharan 
Africa it poses a very difficult and complex public health problem.1 By 2013 glaucoma was estimated 
to affect 64.3 million people aged 40-60 years worldwide, and this is expected to increase to 76.0 
million people by 2020.2 It has also been estimated that 8.4 million would be blind from glaucoma by 
2010 and this is expected to increase to 11.1 million by 2020.3 In a recent review of the epidemiology 
of glaucoma in Sub-Saharan Africa, glaucoma had an estimated prevalence of approximately 4% in 
adults aged 40 years and above where it was responsible for up to 15% of blindness.4 In Nigeria, 
glaucoma is a disease of great public health importance. Recent estimates from the National 
Blindness Survey showed the prevalence of glaucoma was 5.02% in adults over 40 years.5,6   An 
estimated 1.2 million Nigerians are affected with about 1 in 5 persons (20%) already blind from the 
disease. The majority (86%) had primary open angle glaucoma.7 Independent risk factors for open 
angle glaucoma among Nigerians include increasing age, higher intraocular pressure and the Igbo 
ethnic group.8 
In countries with efficient health systems and relatively well educated patients, topical medication is 
usually the first line treatment for glaucoma. However, in Africa, surgery such as trabeculectomy is 
advocated as first line treatment, as patients often present late with advanced disease, and the 
more effective topical medications are either not available or are too expensive.9,10,11,12, However, 
acceptance of surgery can be very low, as reflected by very low output of glaucoma surgery.13,14 
Laser treatment is not widely available in most African countries so medical treatment is the 
norm.15,16,17  
A number of studies report on non-adherence to glaucoma treatment, but few have addressed rates 
of follow up amongst glaucoma patients or factors associated with follow-up, particularly in 
Africa.18,19,20 Identifying factors associated with poor follow-up can help to guide the interventions 
required to improve follow-up and hence reduce the incidence of glaucoma blindness. A study of 
patients attending a glaucoma clinic in Baltimore, USA, showed that those with inconsistent follow-
up were more likely to have mild disease, less likely to have been prescribed glaucoma medication 
and expressed more displeasure with long waiting times in the clinic.21 In another study from the 
United States patients on glaucoma medication and those with more advanced disease were less 
likely to adhere to follow up, whereas in Tamil Nadu, India, inconsistent follow-up was associated 
with little or no formal education, not using glaucoma medication and the perception that follow-up 
is less important when patients are compliant with medication.22,23 In a study from Ibadan, Nigeria 
the following patients were more likely to have dropped out of follow up at one year: younger 
patients, males, patients who travelled long distances to the clinic, those with mild to moderate 
glaucoma, no family history of blinding eye diseases, and those taking two or more topical 
medications24.  
The purpose of this study was to determine rates of follow up among glaucoma patients attending a 
tertiary referral eye department in southern Nigeria, West Africa, and to investigate predictors of 
follow-up documented at time of diagnosis. Findings of interviews with a selected sample of non-
attenders will be reported separately.  
The hospital has a catchment population of over four million most of whom (83%) are below 40 
years of age. Nigeria is ranked third on the world poverty index with about 61% living below the 
poverty level of living on less than 1 USD per day.25 Adult literacy in English is about 62% in the state, 
slightly above the national average (56.9%).26 The hospital has a catchment population of over four 
million, most of whom (83%) are below 40 years of age.  The eye department has facilities for 
glaucoma diagnosis and management, with ten consultant ophthalmologists and trainee positions 
for fifteen ophthalmic residents. The eye department also runs a glaucoma screening service as part 
of a comprehensive medical assessment offered at the Centre for Disease Control at the hospital. 
Nigeria is ranked third on the world poverty index with about 61% living below the poverty level of 
living on less than 1 USD per day.25 Adult literacy in English is about 62% in the state, slightly above 
the national average (56.9%).26   
METHODS 
This was a descriptive retrospective review of case records of adult glaucoma patients.   
Medical records of new glaucoma patients attending the hospital between June 2011 and May 2013 
were compiled from the departmental log book in July 2014. The following patients were eligible: 
aged 16 years and above with a diagnosis of glaucoma confirmed by a consultant ophthalmologist or 
senior ophthalmic resident. Patients with incomplete records, cataract surgery or other surgery 
which might influence routine glaucoma care and frequency of follow up were excluded as were 
glaucoma suspects.  
Data were extracted from medical records by ophthalmology residents trained in the study protocol 
using a structured questionnaire. Socio-demographic data included age, sex, distance from patient’s 
residential address to the facility and occupation. Distance was estimated by calculating the average 
distance by road from the patient’s town/village of residence to the facility. Clinical information at 
diagnosis was extracted, and included best corrected visual acuity (BCVA), presenting intraocular 
pressure (IOP), findings from gonioscopy and visual field analysis, vertical cup:disc ratio (VCDR) 
assessed by direct fundoscopy and slit lamp biomicroscopy with a +78/90D lens. Data on other 
ocular and systemic co-morbidities were also extracted. The number of visits until diagnosis, the 
total number of subsequent visits, and the interval between the most recent visit and the study date 
were determined.  
Categories used in the analysis 
Occupations were grouped into four categories to reflect economic status, and indirectly, education: 
1. high/middle income (i.e., professionals, businessmen and civil servants), 2. low income (i.e., semi-
skilled occupations; artisans, craftsmen, hairdressers, carpenters and unskilled occupations: petty 
traders, farm workers and security guards); 3 very low income (i.e., retired or pensioner groups) who 
often receive some low unspecified income and 4. unemployed/no income (i.e., students, 
housewives, unemployed adults and dependants). Distance to the eye facility was categorised into 
three groups: within 50 kilometres (km) of the facility, 50-100km and greater than 100km. Visual 
acuity was classified using the World Health Organization (WHO) categories of visual loss as not 
impaired i.e., VA in the better eye of 6/18 or better; impaired VA less than 6/18 to 3/60, and blind, 
VA less than 3/60.   
Stage of glaucoma at presentation was graded by eye and then at the person level using the grade in 
the worst affected eye using the following definitions: 1) end stage: VA of hand movements or worse 
with a VCDR of 1.0;  2) advanced: VA 3/60 or worse with VCDR of greater than 0.8 and central visual 
field defects of less than 10 0 of fixation; 3) moderate: any level of VA, VCDR >0.7 (a VCDR cut-off of 
0.7 was used as this was the 97.5th percentile in the Nigeria national survey) with defects within 10-
200 of central fixation, and 4) mild: any other glaucomatous visual field loss and VCDR of 0.7 or 
less.27,28  7 (a VCDR of >0.7 was used as this was the 95th percentile in the Nigeria national survey with 
defects within 10-200 of central fixation, and 4) mild: any other glaucomatous visual field loss and 
VCDR of 0.7 or less.27,28  
The following categories were used to define compliance with follow up using the study date of July 
2014 as the point of reference, based on the fact that glaucoma patients are usually given follow up 
appointments of 6 months or less. Good follow up was defined as attended more than one follow up 
appointment and the last follow up attendance was within 9 months of the study date; inadequate 
follow up: attended more than one follow up appointment with the most recent being 9 -14 months 
from the study date; failed follow up – did not attend a follow up appointment or the most recent 
attendance was more than 14 months from the study date. For univariate and multivariable analysis, 
follow up was categorised as good or poor (inadequate plus failed). 
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Data were entered into an Excel spreadsheet and transferred into IBM SPSS version 22 (Chicago Inc.)  
for analysis. Chi-square (p-values), odds ratio (OR) and 95% confidence intervals were calculated to 
assess associations between follow up and explanatory variables. Multivariable logistic regression 
was used to assess independent predictors of follow-up using a significance level of 0.2 for variables 
used in univariate logistic regression.  
Ethical approval was obtained from the ethics committees of the University of Benin Teaching 
Hospital and the London School of Hygiene &Tropical Medicine and the study was in accordance 
with the provisions of the Helsinki treaty. 
RESULTS 
572 records of glaucoma/glaucoma suspects were reviewed, 348 of whom were eligible for 
inclusion. 54% were male and their mean (SD) age was 52.7 years (SD 18.1; range 16-88 years).  
19.1% of participants were blind and 50.8% had advanced /end stage glaucoma (Table 1).  
Overall 99 (28.4%) participants had good follow-up, 160 (41.6%) had inadequate follow-up and 89 
(25%) failed follow-up. 249/348 (71.6%) had poor follow-up (i.e., inadequate plus failed). The median 
number (interquartile range (IQR)) of visits were as follows: good follow-up: median 6 (IQR 4-10) 
visits; inadequate follow-up median 2 (IQR 1-5) visits and failed follow up 1 (IQR 0-2) visits. Overall, 
261 (75%) patients had two or more follow up visits while 208 (59%) had 3 or more follow up visits.  
Predictors of follow-up 
In univariate analysis, increasing severity of glaucoma was associated with poor follow up. Those 
with moderate, advanced and end-stage glaucoma were 1.2, 2.2 and 5.5 times more likely to have 
poor follow up as those with mild disease (Table 2). Age, sex, occupation, distance to facility, ocular 
and systemic co-morbidity were not significantly associated with follow up. Multivariable logistic 
regression analysis showed that being visually impaired (adjusted odds ratio (OR) 3.85: 95% 
confidence interval (CI) 1.25-11.80; p=0.02); being blind (OR 4.11, 95% CI 1.32-12.81; p=0.02) and 
having end-stage glaucoma at presentation OR 3.55 (95% CI 1.31-9.62; p=0.01) were independently 
associated with poor follow up (Table 2). 
  
Table 1: Table I: Socio-demographic and clinical characteristics of study participants, by level of 
follow up 
Variables 
Sample  overall 
Follow-up (%)  
Good Poor  
(N=348) (N = 99) (N = 249) p-value 
Age group n % of N N % of N N %  
16-39 years 88 25.3 23 23.2 65 26.1 0.92 
40-59 years 104 29.9 32 32.3 72 28.9  
60 years and above 151 43.4 43 43.4 108 43.4  
Missing 5 1.4 1 1.0 4 1.6  
Sex 
Male  188 54.0 50 50.5 138 55.4 0.46 
Female  160 46.0 49 49.5 111 44.6  
Approximate distance to hospital 
    1-50 km 299 85.9 90 90.9 209 83.9 0.24 
    51-100 km 37 10.6 7 7.1 30 12.0  
    >100 km 12 3.4 2 2.0 10 4.0  
Employment/occupation        
High/middle income 95 27.3 27 27.3 68 27.3 0.48 
Low income 105 30.2 33 33.3 72 28.9  
Very low income 88 25.3 26 26.3 62 24.9  
No income/unemployed 51 14.7 10 10.1 41 16.5  
Best corrected visual acuity in better eye 
>6/18 (not impaired) 258 74.1 90 90.9 168 67.5 <0.001 
6/18 – 3/60 (impaired) 36 10.3 4 4.0 32 12.9  
<3/60 (blind) 53 15.2 5 5.1 48 19.3  
Missing 1 0.3 0 0 1 0.4  
Stage of glaucoma at presentation (worse eye) 
Mild  129 37.1 49 49.5 80 32.1 <0.001 
Moderate  65 18.7 22 22.2 43 17.3  
Advanced  95 27.3 21 21.2 74 29.7  
End-stage  58 16.7 6 6.1 52 20.9  
 
 
  
Table 2: Factors associated with poor / failed follow up: univariate and multivariable analysis 
Parameter Univariate analysis Multivariable analysis* 
  
  
Unadjusted OR (95% 
CI) 
p-value 
Adjusted OR 
(95% CI) 
p-value 
Sex     
 Male  1 
 1  
 Female  0.82 (0.52-1.32) 0.41 1.05 (0.62 -1.78)  0.85 
Age group          
 16-39 years 1 
 1  
 40-59  years 0.80 (0.42-1.50) 0.48 0.59 (0.29 - 17) 0.13 
  60 years and above  0.89 (0.49-1,61) 0.70 0.40 (0.18 -0.85) 0.18 
Best corrected visual acuity in better eye  
 ≥6/18 1 
 1  
 <6/18-3/60  4.29 (1.47-12.50) 0.01 3.85 (1.25-11.80) 0.02 
 <3/60 5.13 (1.98-13.38) <0.01 4.11 (1.32-12.81) 0.02 
Stage of glaucoma at presentation (worse eye) 
 Mild  1 
 1  
 Moderate  1.20 (0.64-2.37) 0.57 1.11 (0.57-2.14) 0.77 
 Advanced  2.16 (1.18-3.94) 0.01 1.84 (0.94 -3.62) 0.08 
  End-stage  5.31 (2.12-13.28)  <0.001 3.55 (1.31-9.62) 0.01 
Ocular co-morbidity      
 None  1 
 1  
 Co-morbidity  1.46 (0.91-2.33) 0.12 1.39 (0.74 -2.61) 0.30 
Employment/occupation         
 High/middle income 1 
 - - 
 Low income 0.87 (0.47-1.59) 0.64 
  
 Very low income  0.95 (0.50-1.79) 0.87 
  
  No income/unemployed 1.63 (0.72-3.71) 0.25     
Approximate distance to hospital 
 0-50 km 1 
 - - 
 51-100 km 1.85 (0.78-4.36) 0.16 
  
  >100 km 2.15 (0.46-10.03) 0.33     
  
DISCUSSION 
Regular follow-up is critical in glaucoma care to monitor the disease and adjust treatment when 
necessary. Almost three quarters of the glaucoma patients in our study either failed follow-up or had 
poor follow-up according to our definition, which can be regarded as conservative. A more stringent 
criterion of 4-6 months between visits, which reflects usual practice in our hospital, would likely 
show even lower rates. The rate of poor follow-up (71.6%) is similar to that reported from Ibadan, 
Nigeria where the drop-out rate was 60.5% in the first year and similar to the 75% failure of follow 
up in the first year of care reported from India.24,23   In the United States, non-compliance with follow 
up was lower (40%), but many were glaucoma suspects who were dissatisfied with waiting times.22 
These studies show that poor follow-up is a common and serious problem in glaucoma care 
worldwide. The reasons are likely to be multi-factorial and vary from setting to setting.  In this study 
a sample of glaucoma patients who failed follow up were invited to attend focus group discussions in 
which their reasons for non-attendance were explored. The findings will be reported in another 
paper.    
In this study greater disease severity and visual loss from glaucoma were independently associated 
with poor follow up. This is similar to that reported from the USA in which greater disease severity 
and being on IOP lowering medication were independent risk factors.21 However, the study in India 
had different findings where poor education, non-adherence to medication and the belief that 
follow up is not needed if the vision was stable were significant predictors.23 The differences may 
reflect differences in the setting (high income versus low income) or in the methods used. The USA 
study and this study were both reviews of medical records while that from India was a case control 
study in which a range of subjective parameters were also investigated.  
Poor follow up amongst those with severe disease may reflect lack of independent mobility and the 
need for an escort, which would increase costs. Patients with more severe disease may also be 
discouraged by the irreversible nature of the disease and be reluctant to attend follow-up.  Another 
explanation is that patients may have attended follow up at another service provider, such as the 
private eye hospital in the city, but this is unlikely as only a quarter were categorized as being 
high/middle income.  It is also likely that poor follow up may have led to more severe disease. As this 
study had a cross sectional design, temporality and causality cannot be inferred, and longitudinal 
studies would be required to determine the true sequence of events. Poor follow up may reflect lack 
of understanding of glaucoma i.e., that visual loss cannot be reversed, or lack of acceptance or 
fatalistic views.28 Many studies have confirmed the low level of awareness and understanding about 
glaucoma among the general population, hospital workers as well as glaucoma patients.29,30,31,32.  
In our study the findings at diagnosis were used in the analysis, and data on adherence to topical 
medication or whether glaucoma was subsequently controlled over time were not extracted, which 
might have influenced the findings. For example, someone who became blind soon after diagnosis 
might be less likely to attend for follow up. Collecting data on disease progressions was not possible 
for several reasons: the limited number of follow up visits (only 59% attended 3 or more follow up 
visits) and signs of progression, such as change in visual fields or VCDRs, were not recorded in a 
consistent manner and were recorded by multiple observers.   
Other findings 
Those living more than 50 kilometres from the facility were almost twice as likely to have poor 
follow-up than those living nearer, but the difference was not statistically significant. Distance is 
likely to be associated with greater costs as well as logistical challenges as public transport is limited 
in many parts of Nigeria.  There may also be opportunity costs for patients and those who 
accompany them. Some elderly patients may have used the address of relatives they stayed with for 
the clinic appointment rather than their own address, which would under-estimate the role of 
distance.  
In this study a quarter of participants were less than 40 years of age (mean 52.7 years) which is 
similar to other studies in Nigeria and Africa16,24,33 which supports the earlier age of onset and the 
aggressive course of glaucoma in Africans.34,35 Poor follow up was also high in the younger group 
despite many living within 50km of the facility.  
Almost 20% of the glaucoma patients in this study were blind at presentation using a visual acuity 
(VA) criterion, and half presented with advanced/end stage glaucoma. These findings are consistent 
with an earlier report from his centre   where 25% of new patients were blind using VA criterion and 
55% by visual field criterion.36 Higher rates have been reported in other parts of Nigeria, 31% of 
glaucoma patients were reported blind by VA criterion in the East while in a tertiary unit in Bauchi, 
North east Nigeria, 35% of glaucoma patients were blind and 76% had advanced glaucoma at 
presentation.37,13 High rates of blindness (34%) and advanced glaucoma (70.2%) have also been 
reported amongst glaucoma patients in Ghana, West Africa.33,38 Higher literacy and possibly better 
awareness among the population in the region where our study was undertaken may influence 
health seeking behaviour and hence earlier presentation. This hospital also runs a glaucoma 
screening service which may have led to some cases being identified at an earlier stage of disease.  
 
 
Limitations and strength of study 
The educational status of patients can influence their health seeking behaviour but this could not be 
analysed due to incomplete data. However, occupation, which was used as a proxy for education 
and economic status, did not predict follow up. Information on family history, which may also 
influence adherence to follow up, was also not collected in a consistent manner. Study participants 
were examined by different ophthalmologists which may lead to variation in the diagnosis and 
documentation of glaucoma as this was not standardised. We attempted to adjust for this by only 
including patients diagnosed by senior ophthalmologists. A strength of this study is that it was not 
subject to recall bias and the sample size was large enough to demonstrate statistically significant 
differences. A limitation of the study was that it was a retrospective review of medical records, and 
data were not always recorded in a standard manner and some data were missing.  A prospective 
study is warranted. 
Implications for service delivery and recommendations                                                                                                                                                 
This study shows that poor follow up is significantly associated with greater disease severity and 
poorer visual acuity, and the implications for service delivery are that health education and 
counselling are required for all glaucoma patients, but particularly those with moderate or advanced 
disease and who live far away. This may need to be repeated at each visit, and should include other 
members of the family. Reminding patients about follow up by print or electronic media or using 
mobile text messages or a call-in system to re-schedule appointments has the potential to improve 
follow up in both high and low income countries.39 Most adult Nigerians irrespective of socio-
economic status or location own and use a cell phone, and in this study over 80% of patients had a 
contact telephone number. Coverage of text message reminders has the potential to be high but its 
effectiveness needs to be investigated in this setting. 
The high rate of poor follow-up highlights the need for an acceptable and effective once-off 
intervention which would require less frequent follow up.40 Providers must make determined efforts 
to offer enhanced counselling to glaucoma patients, particularly those with advanced disease, to 
address management options, goals, treatment compliance as well as patients’ expectations and 
challenges. These efforts have the potential to improve follow-up and ultimately reduce the 
incidence of glaucoma blindness.  
For stable patients it is important to develop the capacity of secondary level hospitals so that 
patients can be followed up nearer home. It may be expedient to offer distant glaucoma patients 
who are stable, less frequent follow-up appointments and prescriptions for drugs to last them for 
the intervals between follow-up visits. Laser treatment should be developed as less frequent follow 
up may be required. 
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